chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pain and soreness at injection site right after and for a couple days after the Covid 19  Johnson & Johnson vaccination. I now have dizziness upon waking  beginning on the 13th day after the Covid-19 Johnson & Johnson vaccination (4/23). Still feeling dizzy upon waking as of today 4/27/21, does seem to subside later in the day, but returns the next.
BEGINNING DAY AFTER INJECTIONS, PT COULD NOT LIFT ARMS. SYMPTOMS IMPROVE DAILY AND PATIENT HAS REGAINED ALL FUNCTION.
Initial case received from a consumer, who is also the patient's parent, on 08 October 2009 via another manufacturer (WAES Number 0909USA01985, document number 45226257). A three-month-old female infant experienced a seizure after receiving five vaccines including DTaP (manufacturers and lot numbers not reported). No additional information was reported.
Large area (about 12 cm) erythema/warmth at (L) arm at site of injection. Started about 24 hours after injection.
About 2 hrs after receipt of vaccine, patient spiked temp to 103 deg. had purple feet and blotchy red rash. Seen in ED. Vomited x 3- RR 60, Hr 160's, fretful- Rash legs only. 24 hr F/u - decreased Temp, decreased fussiness. Still with rash- Cleared with Benadryl.
pt recvd vax 24AUG93 & was screaming & screaming & mom could not make pt stop; pt was given APAP; pt exp screaming over 3 hrs & uncontrollable; pt to receive no further pertussis;
Soreness, swelling of arm for 2 days, developed rash on left arm on 3rd day, 4th day had pustule like rash or hives all over entire body. 5th day went to primary doc given script for Prednisone 20 mg. Has taken full course of meds and still has rash (lessened in color and intensity) and terrible itching. Script was for 9 days.
migratory polyarthritis started 25JAN98 & cont for 6-8months;
bleeding heavily; starting a menstrual cycle within weeks of delivery was highly unusual if exclusively breastfeeding; patient was five weeks postpartum and was exclusively breastfeeding the newborn; patient was five weeks postpartum and was exclusively breastfeeding the newborn; This is a spontaneous report from a contactable consumer(patient) who reported for herself  A 38-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot EP7634), in left arm on 18Mar2021 at 15:15 (at 38 years) at single dose for covid-19 immunisation . The patient medical history included five weeks postpartum; concomitant medications were not reported. On 19Mar2021 the patient experienced bleeding heavily and starting a menstrual cycle within weeks of delivery that was highly unusual if exclusively breastfeeding. These events required doctor or other healthcare professional office/clinic visit and were described as follows: patient was five weeks postpartum and was exclusively breastfeeding the newborn. Her body was no longer expelling lochia/blood after the fourth weeks postpartum, however, the day after the vaccine, she began bleeding heavily. This continued on for four days. Her midwife said that ovulation and starting a menstrual cycle within weeks of delivery was highly unusual if exclusively breastfeeding. She didn't attribute to the vaccine until researching on a postpartum message board on What to Expect that there were other anecdotal claims of similar experiences. She would love to speak with someone about what this side effect could possibly mean for her future reproductive health and that if her newborn son.No treatment given; patient was recovering from bleeding heavily and starting a menstrual cycle within weeks of delivery.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021331585 baby case
Initial misuse report received from a healthcare professional on 22 October 2013. The cases were received on 21 March 2014. A 15-month old patient (no other information was provided regarding the patient), received FLUZONE. The patient had received two dose of FLUZONE vaccine last year on unspecified date. It was reported that some leaked out during the administration to a 15 month old when the needle was loose and some leaked out, thus the patient had received vaccine under dose. No adverse event was reported. List of documents held by sender: none.
N/A. VACCINE EXPIRE 10/19/2022. GIVEN ON 10/3/2022 COMPANY REQUIRED VAERS REPORTS TO BE SUBMITTED
On March 2, 2021 I had an ocular migraine in my left eye. On March 3, 2021 I had an ocular migraine in both eyes. On March 4, 2021 it continued in both eyes. On March 5, 2021 I got a rash and my arm swelled up. My whole arm was red. The rash was on my lower arms then the rash started to spread. I started feeling tired and a little feverish on March 9, 2021. In March 2021 I went to see my doctor about it and she said it was probably a reaction to the vaccine. On March 12, 2021 I broke out in shingles, but I think it had it on March 10th because I had a rash that was on my neck, stomach, and arm where I got the vaccine. I got the anti-viral called acyclovir on the 12th of March 2021. The shingles were on the left side and they had spread to my face. This is the first time I had ever had shingles. I started to get a flare up of my scleroderma because my joints were starting to hurt on March 19, 2021. I was also kind of out of breath when walking. My blood pressure would also spike up.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. The patient's pertinent medical history and drug reactions or allergies were not reported. On 05-MAY-2016, the patient was inadvertently administered an expired dose of PNEUMOVAX23 (lot # K018528 and expiration date 14-APR-2016, dose and route of administration were not reported. Concomitant therapy was not reported. No adverse effects were noted. No product quality complaint (PQC) was involved. Additional information has been requested.
MODERNA VACCINE USED WAS USED AND THE RECCOMENDATION FOR THE 30 DAYS IN THE REFRIDGERATOR HAD PASSED BY 6 DAYS.
The vial was initially stored in the refrigerator on 08-Jul-2022 and was administered on 08-Aug-2022.; No Adverse Event; Vaccine administered to the patient after 30-day use by date; This spontaneous case was reported by a physician assistant and describes the occurrence of PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 08-Jul-2022 and was administered on 08-Aug-2022.), EXPIRED PRODUCT ADMINISTERED (Vaccine administered to the patient after 30-day use by date) and NO ADVERSE EVENT (No Adverse Event) in a 12-month-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1414B) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Aug-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 08-Aug-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered to the patient after 30-day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 08-Jul-2022 and was administered on 08-Aug-2022.) and NO ADVERSE EVENT (No Adverse Event). At the time of the report, PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 08-Jul-2022 and was administered on 08-Aug-2022.), EXPIRED PRODUCT ADMINISTERED (Vaccine administered to the patient after 30-day use by date) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessments were provided for PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 08-Jul-2022 and was administered on 08-Aug-2022.) and EXPIRED PRODUCT ADMINISTERED (Vaccine administered to the patient after 30-day use by date).    No concomitant medications were reported. The reporter was not aware of any symptoms for any patient after the vaccine was given. No treatment medications were reported.
I am kind of feeling like hot like feverish; This is a spontaneous report from a contactable consumer (patient).  A 26-year-old male patient received bnt162b2 (BNT162B2 also reported as Pfizer Covid 19 vaccine, lot EL8482), via an unspecified route of administration on 27Jan2021 at SINGLE DOSE for Covid-19 immunisation . Medical history was none. There were no concomitant medications. The patient experienced kind of feeling like hot like feverish on 27Jan2021 and took Tylenol as treatment. The outcome of event was unknown.
Patients father called the pharmacy the next day, less than 24 hours from the time of injection, and stated that the patient woke up with his face and eyes swollen. Patient will be going to his primary care physician
Flu symptoms:  fever, aches, headache, serious coughing and congestion; it is 12 days now and still sick.
Patient had right shoulder swelling and pain increasing in severity with onset 1.5hrs post pneumoccoal vaccine. Swelling in upper deltoid and hand and fingers, Ecchymosis at inferior border of deltoid muscle. Fluid collection. MRI did reveal rotator cuff tear was present.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reaction/allergies or concomitant medication were not reported. On an unknown date, the patient was vaccinated with VARIVAX, intramuscularly (dosage schedule, lot # and expiration date were not reported) for prophylaxis (drug use via unapproved administration route). Furthermore, no adverse effect reported. There was no product quality (PQC) involved. Additional information has been requested.
ITCHY RASH; This spontaneous report received from a patient via a company representative via a social media   concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient previously received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin, and batch number were not reported) dose was not reported,1 total, administered on MAR-2021 for prophylactic vaccination. No adverse events reported post vaccination (dose number in series 1). The patient received covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin, and batch number were not reported) dose was not reported,1 total, administered on NOV-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced itchy rash (dose number in series 2). The patient was just wondering if anyone had developed an itchy rash. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of itchy rash was not reported. This report was non-serious.
3rd nerve palsy..myalgias. Possibly second to vaccine, but more probably to DM.
Pt recv vax on 4/1/98; within 1-2 day pt exp chills, malaise & myalgia x 24 hr
patient experienced aches, tiredness, loss of appetite, and sporadic changes of heartbeat that went upto 130/min upon resting for 18 hours.  Today is day 5 and patient is stable
Large Lymph Node (about 2 inches) Left Arm Injection Site; 2 Inch Redness Injection Site Left Arm; 2 Inch Swelling on the Injection Site Left Arm; A spontaneous report was received from a consumer regarding a 45-year-old female patient who received Moderna's COVID-19 Vaccine, and who developed a large lymph node (about 2 inches) on the injection site, and the injection site was red and swollen (2inches).   The patient's medical history was not provided. Concomitant medications use was not provided by the reporter.   The patient received her first of two planned doses of mRNA-1273 (Lot number 025J20-2A) on 29 Dec 2020 intramuscularly in the left deltoid for prophylaxis of COVID-19 infection.   On 04 Jan 2021, six days post first dose of the COVID  19 vaccine the patient developed a large lymph node (about 2 inches) on the injection site, and the injection site was red and swollen (2 inches). At the time of the report the patient's side effects are getting better. Treatment information was not provided.   Action taken with mRNA-1273 in response to the event(s) was unknown.   The outcome of the events was reported as resolving.; Reporter's Comments: Based on a temporal association and the established safety profile of mRNA-1273 vaccine, a causal association between the reported events and the product use cannot be excluded. The reported events are consistent with the known safety profile of the vaccine.
Patient developed severe swelling surrounding injection site & pain. Gave patient water & diphenhydramine made patient stay in pharmacy additional 15 mins. Patient stated no further swelling. Called patient several hours later & she said she was fine.
ER 7-14-17-Rt Hip pain muscle spasms-"Doctor". It was burning up my feet and legs terrible pain-weak-couldn't stand he sent me home with potassium CL ER and Relafen. Went to office 7/16/17 Diag. spinal stenosis-was not dian w/GBS for 4 wks. Hosp 7-14 (AM). Hosp 7-16 (AM)-diag. spinal stenosis, hosp for 3-4 days-sent to nursing Home for P.T. -they put me in bed or wheelchair and gave me med. Couldn't walk-spilled my food saw P.T. 2-3 times I think, short term memory up to year and 1/2 and no memory of nursing home at all. Dr. put me there. My husband and daughter called him every day finally he said bring her to my office. After conferring with associated they decided to find out what was really wrong. Dr. ordered spinal tap and they found G.B.S. Started med to get it out of my system. Very painful and still is.
I took the vaccine around 4pm in 9th of April, it was ok that day , then i slept at 12am and i woke up shaking after 3 hours having sever chills and fever , after that the other day i had really bad fever and muscle pain , the severity was 8/10 , I couldn?t do anything that day .. but the interesting thing that i have CIA and it?s under control by taking loratidine everyday , but since i took the vaccine my rashes flared up , i got lip swelling, rashes all over my body regardless of taking loratidine as usual , and it?s getting worse at night time now since i took the vaccine.
first dose 2 years ago, not yet received the second; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose of Shingrix received 2 years ago).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The consent to follow-up was granted.
Pt's ILD had been improving with treatment. She was seen 2 weeks prior to vaccine and PFT was improving. Pt received Moderna vaccine on 11/19/21 (pharmacy inside store) - full dose given by pharmacist because pt was on AZA (unclear why full dose was given). Initial series was Pfizer. Fatigue started on 11/26, then dyspnea on 11/27, which worsened by 12/1. Hypoxia then started and outpatient COVID testing was neg. Symptoms worsened further and she was admitted 12/8 for acute hypoxemic respiratory failure requiring ICU admission, High Flow oxygen. Bronchoscopy was negative for infection and rest of workup. CT scan showed diffuse bilateral ground glass opacities concerning with ILD exacerbation. Pt required pulsing with steroids which resulted in improvement of respiratory status and hypoxia, resulting in discharge on 12/14/21.
Information has been received from a healthcare worker concerning a 60 day old infant patient who on 27-APR-2012 might have been inadvertently administered a dose of PNEUMOVAX 23 (Lot#, dose and route not reported) instead of PREVNAR. The reporter was unsure if this did indeed happen and the administration of PNEUMOVAX 23 vaccine to this infant could not be ruled out. No adverse effect reported. It was not known if the patient sought for medical attention. Follow up information has been received from medical assistant refers to a 60 day old female patient who on 27-APR-2012 was vaccinated with a dose of PNEUMOVAX 23 (dose and duration not reported) (lot # reported as F89912). On the same day the patient received a dose of LIQUID PEDVAXHIB (dose, route not reported) lot # reported as 1475AA, a dose of ROTATEQ (dose and route not reported) lot# reported as 0529AA, and a dose of PEDIARIX. The medical assistant stated that the office used an electronic records system. The office had scheduled vaccines for the patient at 2, 4 and 6 months and pre-entered the lot numbers of the vaccines into the system. The medical assistant stated that the pediatric nurse who administered the vaccines to the patient may had inadvertently entered PNEUMOVAX 23 instead of PREVNAR when she was documenting the vaccine that was administered. The medical assistant stated that they are "pretty sure" the patient received the PREVNAR vaccine and not PNEUMOVAX 23. The medical assistant stated that the patient was in the office in June 2012 and was fine at that time. Additional information is not expected.
From initial information received on 09/27/2004 from a health care professional regarding an adverse event occurring in the U.S.A., it was reported  that a female patient received her 5 th dose of Daptacel vaccine, lot number C1996AA, administered on 09/23/2004. That same day the patient also received a dose of Act Hib vaccine, a dose of IPV vaccine, a dose of Prevnar vaccine and a dose of MMR/Measles, Mumps, and Rubella vaccine(manufacturer unknown). Information regarding the lot numbers, the dose, the route and site of administration were not reported for these vaccinations. Reportedly, within 24 hours of administration the patient developed a large red blotch and an area that was warm to the touch around the injection site, exact site not specified, that lasted 4-5 days. Reportedly the patient recovered from this event. From additional information received on 11/02/04 from a health care professional, the patient's date of birth was provided. The patient was four months old at the time of the event. Reportedly the patient received her second dose of Daptacel, lot number, C1996AA, administered IM in the left thigh, her first dose of Act Hib lot number UE250A (aventis pastuer lot number X0703) administered IM in the right thigh, a second dose of Prevnar, lot number A57559A, manufacturer Lederle, administered IM in the right thigh and a dose of MMR manufacturer unknown,  (lot number, route and site of administration not reported) on 09/23/2004. Reportedly the patient developed the adverse event at 3:30 pm that same day, 09/23/2004. No further information is anticipated. This case is considered closed. The reporter for this case is the same for cases;200403223, 200403224, and 200403225.
Approximately 24 hours after I got the shot, I started to get a migraine with some pretty bad nausea. That lasted for 4 days. The migraine went away but I continued to get episodes of nausea. I experienced indigestion, severe nausea, intestinal discomfort, a little bit of acid build up, no diarrhea or vomiting.  I started to track my food and I made the connection that it was triggered by a food. I went to see my doctor and she said it could be a gluten intolerance and she explained that any vaccine can cause inflammation and maybe that is what happened to me. The treatment right now is to eliminate gluten and try to reduce the inflammation. I have not had any episode in the last week because I am avoiding the foods. She said we will try again in a month to see if I can tolerate the food. We did a celiac test, and it came back negative and a physical exam. I had my flu shot after the booster.
Shingles on forehead in the V 1 distribution with associated pain in the V 1 distribution areas, not including eye. No history of wild type chicken pox. Vaccinated x 2 for varicella.
10/23/08 pt saw school nurse for redness, soreness and warmth noted at vaccination site - Parent called Ped clinic 10/24/08 b/c site redness spreading Dr. saw site. RXN to flu shot given 10/22/08 ( BENADRYL ).
Left thigh red and swollen hot to touch. Tx. ice packs and Benadryl
Systemic: Body Aches Generalized-Severe, Systemic: Confusion-Medium, Systemic: Exhaustion / Lethargy-Medium, Additional Details: Patient reported psychiatric type side effects. She felt like her "biceps were going through her skin" as stated verbatim by her. She has never had a side effect like this and she wants it reported. Her daughter also reported having an out of body feeling after covid booster and her husband felt like he was high.
Pt has a history of hypertension and HLD with complaints of chest pain that has been intermittent for the last week.  Pt does have a dry cough.  COVID testing was positive.
Information has been received from a registered nurse concerning a 26 year old female with a penicillin allergy and no medical history, who in January 2007, was vaccinated with a first dose of GARDASIL.  There was no concomitant medication.  In approximately January 2008, the patient developed a reddened injection site and then a delayed onset of fatigue three weeks later.  It was also reported that the patient had an abnormal papanicolaou test (it was negative for human papillomavirus).  It was also reported that the patient was under the care of another provider.  The patient did not seek medical treatment for the symptoms.  Subsequently, the patient recovered.  No product quality complaint was involved.  Additional information has been requested.
mild fever; This is a spontaneous report received from a non-contactable consumer or other non hcp. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number was not reported) via an unspecified route of administration on an unspecified date as dose number unknown, single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced mild fever on an unspecified date with outcome of unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Headache, Myalgia, Arthralgia, Fever & NauseaVomiting Narrative: dose 1: day 2 fever joint and muscle ache dose 2: day 2 pain; nausea; ha; day3: fever joint and muscle ache
Severe abdominal pain, 3 days; followed by moderate pain, several days. Accompanied by nausea, and later by sore abdominal muscles.
As of now it's been only 46 hours.  Shoulder pain gradually developed over the first few hours.  After 3-4 hours, the pain was so intense that I couldn't lift my arm above my chest.  I had extremely limited shoulder mobility.  I had extreme pain that limited my ability to sleep.  The pain just started to ease up, and mobility is slowly returning, but I am far from normal.  I had to take sick leave from my job.  I believe I am suffering from SIRVA.  The injection point was oddly high on my shoulder.